Novartis India Ltd. benchmarking: Performance to industry peers

Financial

	Novartis	Bliss GVS Pharma	Orchid Pharma
Operational Metrics
Pharmaceuticals
Domestic Sales Growth - YoY	-5.28 %	n/a	n/a
Financials
5 yr Average ROE	8.11 %	6.83 %	4.49 %
5yr average Equity Multiplier	2.72	1.3	1.61
5yr Average Asset Turnover Ratio	0.18	0.62	0.5
5yr Avg Net Profit Margin	17.12 %	8.7 %	0.56 %
Price to Book	3.19	2.21	2.11
P/E	25.4	22.98	142.68
5yr Avg Cash Conversion Cycle	-23.33 Days	186.56 Days	52.03 Days
Inventory Days	44.27 Days	54.35 Days	112.47 Days
Days Receivable	38.18 Days	189.93 Days	86.58 Days
Days Payable	124.28 Days	75.78 Days	159.29 Days
5yr Average Interest Coverage Ratio	65.43	14.68	3.01
5yr Avg ROCE	5.91 %	13.27 %	3.08 %
5yr Avg Operating Profit Margin	15.15 %	17.03 %	11.84 %
5 yr average Debt to Equity	0.0	0.11	0.37
5yr CAGR Net Profit	37.01 %	4.24 %	n/a
5yr Average Return on Assets	3.13 %	5.31 %	1.2 %
Shareholdings
Promoter Holding	70.68 %	35.36 %	69.84 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	0.9 %	-20.12 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	15.56 %

	Novartis	Bliss GVS Pharma	Orchid Pharma
Product Wise Break-Up	Product Wise Break-Up Wholesale of pharmaceuticals and medical goods 100.0 Anti Inflammatory 0 Anti-biotic 0 Anti-bacterial 0 Anti-fungal, 0 Antimalarial 0 Sterile 0 Oral Formulations 0	Product Wise Break-Up Anti-bacterial 0 Oral Formulations 0 Anti-fungal 16.0 Anti Inflammatory 7.0 Anti Malarials 43.0 Antibiotics 5.0 Sterile 0 0 Others 29.0	Product Wise Break-Up Anti-bacterial 0 Oral Formulations 72.44 Anti-fungal, 0 Anti Inflammatory 0 Antimalarial 0 Anti-biotic 0 Sterile 27.56 0
Location Wise Break-Up	Location Wise Break-Up India 100.0 Rest of the World 0	Location Wise Break-Up India 6.61 Rest of the World 93.39	Location Wise Break-Up India 19.9 Rest of the World 0 Others 80.1